Phase 3 Depression and Anxiety Trial, Recruiting NCT07221578 Sponsor: Vanda Pharmaceuticals Condition: Depression and Anxiety
Back to Depression And Anxiety

Phase 3 Depression and Anxiety Trial, Recruiting

NCT07221578
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are willing and able to give written consent to participate.
  • People aged 18 to 65 years (male or female).
  • People who have a current diagnosis of social anxiety disorder.
  • People whose social anxiety symptoms score at least 60 on a standard medical rating scale called the Liebowitz Social Anxiety Scale.
  • People whose fear of public speaking scores at least 60 on a standard rating scale called the Public Speaking Anxiety Scale.
  • People whose depression symptoms score 18 or below on a standard rating scale called the Hamilton Depression Rating Scale.

Who may not be able to join:

  • People who have attempted suicide or had thoughts of suicide in the past 2 years, or who the trial doctor considers to be currently at risk of suicide.
  • People with a history of bipolar disorder, schizophrenia, psychosis, seizures, delusional disorders, obsessive-compulsive disorder (OCD), or autism spectrum disorder.
  • People who have had post-traumatic stress disorder (PTSD) or an eating disorder in the past 6 months.
  • People who have had a substance or alcohol use disorder in the past 6 months, or who test positive in a drug or alcohol screening.
  • People who have received any form of talking therapy (psychotherapy) in the past 6 months.
  • People who have taken any medications that affect mood or mental health in the past 2 months.
  • People who are currently pregnant, planning to become pregnant, or breastfeeding during the trial period.
  • People whom the trial doctor considers unsuitable for any other reason related to safety or the goals of the trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 202-734-3400

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Sponsor
Vanda Pharmaceuticals
Registry
ClinicalTrials.gov
Start date
22 September 2025
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Subjective Units of Distress Scale (SUDS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov